作者
Bernard Lerer, Fabìo Macciardi, Ronnen H Segman, Rolf Adolfsson, D Blackwood, Sylvie Blairy, J Del Favero, DG Dikeos, R Kaneva, R Lilli, Isabelle Massat, V Milanova, W Muir, M Noethen, L Oruc, T Petrova, GN Papadimitriou, Marcella Rietschel, A Serretti, Daniel Souery, Sofie Van Gestel, Christine Van Broeckhoven, Julien Mendlewicz
发表日期
2001/9
期刊
Molecular psychiatry
卷号
6
期号
5
页码范围
579-585
出版商
Nature Publishing Group
简介
Substantial evidence supports a role for dysfunction of brain serotonergic (5-HT) systems in the pathogenesis of major affective disorder, both unipolar (recurrent major depression) and bipolar. 1 Modification of serotonergic neurotransmission is pivotally implicated in the mechanism of action of antidepressant drugs 2 and also in the action of mood stabilizing agents, particularly lithium carbonate. 3 Accordingly, genes that code for the multiple subtypes of serotonin receptors that have been cloned and are expressed in brain, 4 are strong candidates for a role in the genetic etiology of affective illness. We examined a structural variant of the serotonin 2C (5-HT2C) receptor gene (HTR2C) that gives rise to a cysteine to serine substitution in the N terminal extracellular domain of the receptor protein (cys23ser), 5 in 513 patients with recurrent major depression (MDD-R), 649 patients with bipolar (BP) affective disorder and …
引用总数
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120221111412181414191012697111010464665